Replies to post #198437 on Anavex Life Sciences Corp (AVXL)

[anders2211]

If you read my post, you even quoted it, I did not say I have read the end results.

Neuren conducted a Phase 2 double-blind placebo-controlled clinical trial in subjects aged 12 to 45 years with Rett syndrome, in which treatment with trofinetide showed clinical improvement in many of the core symptoms of Fragile X syndrome

http://www.neurenpharma.com/irm/content/nnz-2566-in-fragile-x-syndrome.aspx?RID=331

and

https://www.girlpower2cure.org/our-cause/blog/the-summer-of-hope-and-adele/